Drugmaker Abbott India posts Q4 profit rise on higher sales [Reuters]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Reuters
The company, which makes the popular antacid medicine Digene, said its profit rose to 2.87 billion rupees ($34.3 million) for the three months ended March 31, from 2.31 billion rupees a year earlier. Revenues of drugmakers such as Abbott India and GlaxoSmithKline Pharma India , which get most of their business from India, have been impacted after the inclusion of some of their drugs in the government's essential medicines list in September 2022, making them susceptible to price caps. Abbott, which is a unit of U.S. healthcare firm Abbott Laboratories , has been trying to mitigate the impact of pricing curbs by driving up sales and cutting back on expenses. The company, which makes drugs including hypothyroidism treatment tablets Thyronorm, said its revenue from operations rose 7% to 14.39 billion rupees in the fourth quarter. The company declared a dividend of 410 rupees per share for fiscal year 2024. ($1 = 83.4760 Indian rupees) Keep up with the latest medical breakthro
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- In-Vitro Diagnostic (IVD) Quality Control Market Research Report 2024-2028: Control Materials, QC Procedures, Instrument Calibration, Documentation and Record Keeping, Troubleshootin [Yahoo! Finance]Yahoo! Finance
- Global Companion Diagnostics Industry Research 2024: Epigenomics-Based Companion Diagnostics, Advancing Biomedical Imaging Fueling Growth - Forecast to 2033 [Yahoo! Finance]Yahoo! Finance
- Abbott (ABT) Down 0.4% Since Last Earnings Report: Can It Rebound? [Yahoo! Finance]Yahoo! Finance
- Polycystic Ovary Syndrome (PCOS) Treatment Global Strategic Research Report 2024-2030: North America and Europe Dominates, Asia-Pacific to Exhibit Fastest Growth [Yahoo! Finance]Yahoo! Finance
- Global Dietary Supplements Market is Anticipated to Reach USD 380.12 Billion at a CAGR of 8.8% CAGR by 2032 - Report by Polaris Market Research (PMR) [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 5/14/24 - Form 4
- 5/10/24 - Form 144
- 5/8/24 - Form 4
- ABT's page on the SEC website